Subscribe to RSS
DOI: 10.1055/s-2005-865079
© Georg Thieme Verlag Stuttgart · New York
Kardiologische Intensivmedizin - das akute Koronarsyndrom
Intensive care in cardiovascular medicine - acute coronary syndromePublication History
eingereicht: 8.12.2004
akzeptiert: 9.3.2005
Publication Date:
18 March 2005 (online)

Die internistische Intensivmedizin wird in einem breiten Bereich durch kardiologische Krankheitsbilder mitbestimmt. Dadurch betroffen sind das akute Koronarsyndrom/ der akute Myokardinfarkt, schwerwiegende Arrhythmien, die akute und akut dekompensierte chronische Herzinsuffizienz, das akute Cor pulmonale/ die akute Lugenembolie, aber auch Mitreaktionen des Herz-Kreislauf-Systems im Rahmen von Systemerkankungen (Sepsis, die verschiedenen Schockformen). Für diesen Artikel wurden stellvertretend die Therapie des akuten Koronarsyndromes/ des akuten Herzinfarktes und schwerwiegender Arrhythmien ausgewählt. Das akute Koronarsyndrom nimmt eine wichtige Stellung ein. Bei steigender Prävalenz der koronaren Herzerkrankung stellen Patienten mit diesen Krankheitsbildern einen Großteil kardiologisch kranker Patienten in der Intensivmedizin dar. Das akute Koronarsysndrom umfasst die instabile Angina pectoris, den nicht-transmuralen und den transmuralen Myokardinfarkt. Die diagnostischen und therapeutischen Möglichkeiten dieser Entität sowie von supraventrikulären und ventrikulären Arrhythmien werden in diesem Artikel dargestellt und der aktuelle Stand vermittelt.
Literatur
- 1
Antoniucci D, Santoro G M, Bolognese L. et al .
A clinical trial comparing primary stenting of the infarct-related artery with optimal
angioplasty for acute myocardial infarction. Results from the Florence randomized
elective stenting in acute coronary occlusions (FRESCO) trial.
J Am Coll Cardiol.
1998;
31
1234-1239
Reference Ris Wihthout Link
- 2
Bertrand M E, Simoons M, Fox K A. et al .
Management of acute coronary syndromes in patients presenting without persistent ST-segment
elevation. The Task Force on the Management of Acute Coronary Syndromes of the European
Society of Cardiology.
Eur Heart J.
2000;
23
1809-1840
Reference Ris Wihthout Link
- 3
Brener S J, Barr L A, Burchenal J EB. et al .
Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with
primary angioplasty for acute myocardial infarction.
Circulation.
1998;
98
734-741
Reference Ris Wihthout Link
- 4
Cannon C P, Weintraub W S, Demopoulos L A. et al .
Comparison of early invasive and conservative strategies in patients with unstable
coronary syndromes treated with the Glycoprotein IIb/IIIa inhibitor tirofiban.
N Engl J Med.
2001;
344
1879-1887
Reference Ris Wihthout Link
- 5
Coyne K S, Lundergan C F, Boyle D. et al .
Relationship of infarct artery patency and left ventricular ejection fraction to health-related
quality of life aftr myocardial infarction.
Circulation.
2000;
102
1245-1251
Reference Ris Wihthout Link
- 6
Cura F A, Bhatt D L, Lincoff A M. et al .
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa
inhibition in complex atherosclerosis lesions.
Circulation.
2000;
102
28-34
Reference Ris Wihthout Link
- 7
Davies M J, Thomas A C.
Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death,
and crescendo angina.
Br Heart J.
1985;
53
363-373
Reference Ris Wihthout Link
- 8
Desai A D, Chun S, Sung R J.
The role of intravenous amiodarone in the management of cardiac arrhythmias.
Ann Intern Med.
1997;
127
294-303
Reference Ris Wihthout Link
- 9
Domanovits H, Schillinger M, Thoennissen J. et al .
Termination of recent-onset atrial fibrillation/flutter in the emergency department:
a sequential approach with intravenous ibutilide and external electrical cardioversion.
Resuscitation.
2000;
45
181-187
Reference Ris Wihthout Link
- 10
Donaldson L, Grant L S, Naysmith N R. et al .
Acute amiodarone-induced lung toxicity.
Intensive Care Med.
1998;
24
626-630
Reference Ris Wihthout Link
- 11
Erbel R, Heusch G.
Spontaneous and iatrogenic microembolization. A new concept for the pathogenesis of
coronary artery disease.
Herz.
1999;
24
493-495
Reference Ris Wihthout Link
- 12
Wallentin L. FRISC Study Group .
Invasive compared with non-invasive treatment in unstable coronary-artery disease:
FRISC II prospective randomised multicentre study.
Lancet.
1999;
354
708-715
Reference Ris Wihthout Link
- 13
Gawaz M, Neumann F -J, Ott I. et al .
Platelet Function in Acute Myocardial Infarction Treated With Direct Angioplasty.
Circulation.
1996;
93
229-237
Reference Ris Wihthout Link
- 14
Grines C L, Cox D A, Stone G W. et al .
Coronary Angioplasty With or Without Stent Implantation For Acute Myocardial Infarction.
N Engl J Med.
1999;
341
1949-1956
Reference Ris Wihthout Link
- 15
Topol E J, Califf R M. et al. GUSTO .
A comparison of recombinant hirudin with heparin for the treatment of acute coronary
syndromes.
N Engl J Med.
1996;
335
775-782
Reference Ris Wihthout Link
- 16
Hamm C W, Arntz H R, Bode C. et al .
Leitlinien: Akutes Koronarsyndrom (ACS). Teil 1: ACS ohne persistierende ST-Hebung.
Z Kardiol.
2004;
93
72-90
Reference Ris Wihthout Link
- 17
Hamm C W, Arntz H R, Bode C. et al .
Leitlinien: Akutes Koronarsyndrom (ACS). Teil 2: Akutes Koronarsyndrom mit ST-Hebung.
Zeitschrift für Kardiologie.
2004;
93
324-341
Reference Ris Wihthout Link
- 18
Hamm C W, Heeschen C, Goldmann B. et al .
Benefit of abciximab in patients with refractory unstable angina in relation to serum
troponin T levels.
N Engl J Med.
1999;
340
1623-1629
Reference Ris Wihthout Link
- 19
Hennersdorf M G, Evers S, Perings C. et al .
Antiarrhythmische Therapie von Vorhofflimmern.
Herzschr Electrophysiol.
2001;
12
86-94
Reference Ris Wihthout Link
- 20
Hennersdorf M G, Perings S M, Zuhlke C. et al .
Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone
has failed.
Intensive Care Med.
2002;
28
925-929
Reference Ris Wihthout Link
- 21
Kelm M, Strauer B E.
Akuter Myokardinfarkt - primäre Angioplastie oder Thrombolyse?.
Internist.
2000;
41
1331-1343
Reference Ris Wihthout Link
- 22
Knotzer H, Mayr A, Ulmer H. et al .
Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic
study.
Intensive Care Med.
2000;
26
908-914
Reference Ris Wihthout Link
- 23
Kudenchuk P J, Cobb L A, Copass M K. et al .
Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular
fibrillation.
N Engl J Med.
1999;
341
871-878
Reference Ris Wihthout Link
- 24
Landau C, Glamann D B, Willard J E. et al .
Coronary angioplasty in the patient with acute myocardial infarction.
Am J Med.
1994;
96
536-543
Reference Ris Wihthout Link
- 25
Lieu T A, Gurley R J, Lundstrom R J. et al .
Primary angioplasty and thrombolysis for acute myocardial infarction: an evidence
summary.
J Am Coll Cardiol.
1996;
27
737-750
Reference Ris Wihthout Link
- 26
Lincoff A M, Tcheng J E, Califf R M. et al .
Sustained suppresion of ischemic complications of coronary intervention by platelet
GP IIb/IIIa blockade with abciximab-One-year outcome in the EPILOG trial.
Circulation.
1999;
99
1951-1958
Reference Ris Wihthout Link
- 27
Martínez-Marcos F J, García-Garmendia J L, Ortega-Carpio A. et al .
Comparison of intravenous flecaninde, propafenone, and amiodarone for conversion of
acute atrial fibrillation to sinus rhythm.
Am J Cardiol.
2000;
86
950-953
Reference Ris Wihthout Link
- 28
Neumann F -J, Blasini R, Schmitt C. et al .
Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and
left ventricular function after the placement of coronary-artery stents in acute myocardial
infarction.
Circulation.
1998;
98
2695-2701
Reference Ris Wihthout Link
- 29
Ohman E M, Califf R M, Topol E J. The TAMI Study Group .
Consequences of reocclusion after successful reperfusion therapy in acute MI.
Circulation.
1990;
82
781-791
Reference Ris Wihthout Link
- 30
Peter K, Kohler B, Straub A. et al .
Flow cytometric monitoring of glyycoprotein IIb/IIIa blockade and platelet function
in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine
- Continuous platelet inhibition by the combination of abciximab and ticlopidine.
Circulation.
2000;
102
1490-1496
Reference Ris Wihthout Link
- 31
Podrid P J.
Amiodarone: Reevaluation of an old drug.
Ann Intern Med.
1995;
122
689-700
Reference Ris Wihthout Link
- 32
Prystowsky E N.
Management of atrial fibrillation: Therapeutical options and clinical decisions.
Am J Cardiol.
2000;
85
3D-11D
Reference Ris Wihthout Link
- 33
Reinelt P, Karth G D, Geppert A. et al .
Incidence and type of cardiac arrhythmias in critically ill patients: a single center
experience in a medical-cardiological ICU.
Intensive Care Med.
2001;
27
1466-1473
Reference Ris Wihthout Link
- 34
Schömig A, Neumann F -J, Kastrati A. et al .
A randomized comparison of antiplatelet and anticoagulant therapy after the placemant
of coronary-artery stents.
N Engl J Med.
1996;
334
1084-1089
Reference Ris Wihthout Link
- 35
Schrör K.
Endotheliale Faktoren und Thrombozytenfunktion.
Z Kardiol.
1991;
80
3-6
Reference Ris Wihthout Link
- 36
Seguin P, Signouret T, Laviolle B. et al .
Incidence and risk factors of atrial fibrillation in a surgical intensive care unit.
Crit Care Med.
2004;
32
722-726
Reference Ris Wihthout Link
- 37
Society of Cardiology .
Myocardial infarction redefined - a consensus document of the joint european society
of cardiology/american college of cardiology committee for the redefinition of myocardial
infarction.
J Am Coll Cardiol.
2000;
36
959-970
Reference Ris Wihthout Link
- 38
Stambler B S.
Ibutilide.
Cardiac Electrophysiology Review.
1998;
2
173-175
Reference Ris Wihthout Link
- 39
Suryapranata H, van’t Hof A W, Hoorntje J C. et al .
Randomized comparison of coronary stenting with bolloon angioplasty in selected patients
with acute myochardian infarction.
Circulation.
1998;
97
2502-2505
Reference Ris Wihthout Link
- 40
Suttorp M J, Kingma J H, Lie-A-Huen L.
Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial
fibrillation or flutter to sinus rhythm.
Am J Cardiol.
1989;
63
693-696
Reference Ris Wihthout Link
- 41
Topol E J, Holmes D R, Rogers W J.
Coronary angiography after thrombolytic therapy for acute myocardial infarction.
Ann Intern Med.
1991;
114
877-885
Reference Ris Wihthout Link
- 42
Topol E J, Yadav J S.
Recognition of the importance of embolization in atherosclerotic vascular disease.
Circulation.
2000;
101
570-580
Reference Ris Wihthout Link
- 43
Volgman A S, Carberry P A, Stambler B S.
Conversion efficacy and safety of intravenous ibutilide compared with intravenous
procainamide in patients with atrial flutter or fibrillation.
J Am Coll Cardiol.
1998;
31
1414-1419
Reference Ris Wihthout Link
- 44
Vos M A, Golitysn S R, Stangl K. et al .
Superiority of ibutilide (a new class III agent) over dl-sotalol in converting atrial
flutter and atrial fibrillation.
Heart.
1998;
79
568-575
Reference Ris Wihthout Link
- 45
Weaver W D, Simes R J, Betriu A. et al .
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for
acute myocardial infarction. A quantitative review.
JAMA.
1997;
278
2093-2098
Reference Ris Wihthout Link
- 46
Wu K C, Zerhouni E A, Judd R M. et al .
Prognostic significance of microvascular obstruction by magnetic resonance imaging
in patients with acute myocardial infarction.
Circulation.
1998;
97
765-772
Reference Ris Wihthout Link
- 47
Zeltser D, Justo D, Halkin A. et al .
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit
drug.
J Am Coll Cardiol.
2004;
44
105-108
Reference Ris Wihthout Link
- 48
Zijlstra F, Hoorntje J CA, De Boer M J. et al .
Long-term benefit of primary angioplasty as compared with thromobolytic therapy for
acute myocardial infarction.
N Engl J Med.
1999;
341
1413-1419
Reference Ris Wihthout Link
- 49
Schneider H, Weber F, Paranskaja L, Holzhausen C, Petzsch M, Severin R, Nienaber C A.
Leitlinienkonforme interventionelle Therapie des akuten ST-Hebungsinfarkt in ländlichen
Gebieten durch Netzwerkbildung.
Dtsch Med Wochenschr.
2004;
129
2162-2166
Reference Ris Wihthout Link
Priv.-Doz. Dr. med. Marcus G. Hennersdorf
Medizinische Kinik und Poliklinik B, Klinik für Kardiologie, Pneumologie und Angiologie,
Heinrich-Heine-Universität
Moorenstraße 5
40225 Düsseldorf
Phone: 0211/8118800
Fax: 0211/8119520
Email: hennersdorf@med.uni-duesseldorf.de